Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Pd Article
This is a selection made from among articles on Drug Treatment Pd. For a permanent link to this article, or to bookmark it for future reading, click here.
How To Know And Help A Drug Addict.
from:
How To Know And Help A Drug Addict.
What is drug addiction?
Drug addiction is a brain disease affecting the emotions and behavior. It is distinguished by drug craving, seeking, and use. A person addicted to drugs will persist even in the face of extremely negative consequences. Drug-seeking may become compulsive in large part as a result of the effects of prolonged drug use on brain functioning and, thus, on behavior.
How quickly can drug adiction happen?
There is no easy answer to this. How quickly a person becomes addicted to a drug depends on many factors including the biology of your body. All drugs are potentially harmful and may have life-threatening consequences associated with their abuse. There are also vast differences among individuals in sensitivity to various drugs. While one person may use a drug one or many times and suffer no ill effects, another person may be particularly vulnerable and overdose with first use. There is no way of knowing in advance how someone may react.
How can you tell if someone is addicted to drugs?
If a person is compulsively seeking and using a drug despite negative consequences, such as loss of job, debt, physical problems brought on by drug abuse, or family problems, then he or she probably is addicted.
What are the physical signs of abuse or addiction?
The physical signs of abuse or addiction can vary depending on the person and the drug being abused. For example, someone who abuses marijuana may have a chronic cough or worsening of asthmatic symptoms. Each drug has short-term and long-term physical effects. Stimulants like cocaine increase heart rate and blood pressure, whereas opioids like heroin may slow the heart rate and reduce respiration.
Are there effective treatments for drug addiction?
Drug addiction can be effectively treated with behavioral-based therapies and, for addiction to some drugs such as heroin or nicotine, medications. Treatment will vary for each person depending on the type of drug(s) being used, and multiple courses of treatment may be needed to achieve success.
How do I help somebody That is addicted to drugs?
Professional help is the best help. There are many types of drug rehabilitation programs available. Research which one will be best suited to your needs and contact them. You will find people ready and willing to help.
About Author
For more information on drug and alcohol addiction or drug rehab centers visit: http://www.drug-rehab-news.com
Source: ArticleTrader.com
Drug Treatment Pd Specific links
Drug Treatment Pd News
Clinical trial participation might help discover a cure for Parkinson's
Clinical trials are central to Parkinson's disease (PD) treatment breakthroughs and, ultimately, a cure.
Read more...Zytoprotec completes PD-protec Phase I/II trial on kidney failure
Zytoprotec, a company developing drugs based on active cytoprotection, today announced the completion of a Phase I/II clinical trial with its lead product, PD-protec.
Read more...Baxter’s Low Glucose PD Solutions Favorably Impacted Metabolic Measures Including Glycemic Control in Trials of ...
Baxter International Inc. today announced results from two large, international multicenter trials demonstrating that a low glucose peritoneal dialysis regimen favorably impacted metabolic measures important for end-stage renal disease patients with diabetes, including blood glucose control and selected lipids .
Read more...Curis Announces Collaborators' Presentation of Erivedge(TM) and Debio 0932 Clinical Data at ASCO Annual Meeting
LEXINGTON, Mass. -- Curis, Inc. , a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that several abstracts on its ...
Read more...Michael J. Fox Foundation Expands Funding to Envoy
Envoy Therapeutics, Inc., a drug discovery company, today announced that it has been awarded a second grant from The Michael J. Fox Foundation . The additional funding will enable the continued development of compounds that selectively act on the motor circuitry that is compromised in Parkinson’s disease via modulation of a receptor target identified by Envoy.
Read more...ChemoCentryx Presents Data on CCX168, an Orally Administered Small Molecule Inhibitor of C5aR, at the 49th European ...
MOUNTAIN VIEW, Calif. -- ChemoCentryx, Inc. , today announced the presentation of results from the Company's development program for CCX168, an investigational orally administered inhibitor of the complement ...
Read more...Phase I/II clinical trial of novel dialysate completed by Zytoprotec
Zytoprotec, a company developing drugs based on active cytoprotection, today announced the completion of a Phase I/II clinical trial with its lead product, PD-protec™. The product is developed to improve the treatment of patients with kidney failure.
Read more...Ohio must sustain anti-drug funding: editorial
A 77 percent increase in heroin overdoses over the last five years in Cleveland, along with a 176 percent rise for those living in the Cuyahoga County suburbs, demonstrate forcefully that now is not the time for the state to cut funding of addiction treatment services for the indigent and uninsured, The Plain Dealer editorial board writes.
Read more...Text Message Prescription Reminders Significantly Improve Patient Adherence to Oral Diabetes Medication
A new study published in the May issue of Clinical Therapeutics shows that patients who participate in a text message prescription reminder program have significantly higher adhere
Read more...Parkinson's Disease Neuropsychiatric Features And Fatigue Respond To Transdermal Rotigotine
At the 64th American Academy of Neurology Annual Meeting in New Orleans USA, UCB presented results from their post-hoc analyses of Neupro (rotigotine), which suggests that the drug improves common non-motor symptoms in patients with Parkinson's disease. In the EU, Neupro® (rotigotine) is approved for the treatment of the signs and symptoms of early-stage idiopathic Parkinson's disease as a ...
Read more...